Trestle Biotherapeutics, Inc., today announced a research collaboration with Humacyte, Inc. (Nasdaq: HUMA), a ...

The honor recognizes Health First’s patient care and outcomes relative to isolated coronary artery bypass grafting procedures.

transplant vasculopathy and vein bypass graft failure is particularly important. Thus, an emerging strategy for the treatment of those conditions is to inhibit cellular proliferation by targeting ...

The MAQUET line of FUSION grafts Graft merges ePTFE with PET, creating a completely new concept for peripheral vascular procedures ... the standard for peripheral bypass treatment.

Although the surgical quality (number of grafts, clamp time, cardiopulmonary bypass time ... pump failure requiring IABP support, cerebral vascular accident, and respiratory failure were the ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape ...

With the highest quality materials, a unique manufacturing technique and advanced sealant technology, the AlboGraft Vascular Graft offers ... of the course of the bypass under x-ray.

Ichor Vascular, Inc. announced the limited market release of its 7-F peripheral reperfusion system. In July 2024, the compa ...

A new study published in the journal of Circulation showed that the use of anabolic androgenic steroids (AASs) has been linked in a large cohort with a lengthy follow-up period to a ...

Health First's Heart & Vascular Program received a three-star rating from the Society of Thoracic Surgeons for its coronary artery bypass graft procedures. The STS star rating system is one of the ...